HIGHLIGHTS
- who: Sara Jennrich from the Aarau Cantonal Hospital, Switzerland University of Miami Health System have published the research work: CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy, in the Journal: (JOURNAL)
- what: According to ATCC, U373 cells used in this work show genetic similarities to U251 glioblastoma cells. The experiments demonstrate that irradiation with photons and low beams. Since the authors barely detected CD63-positive sEVs in supernatants of the glioblastoma cells in preliminary experiments, the authors focused the examinations on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.